Evaluation of the Vivo Isar Stent System in Routine Clinical Practice
Multicenter Observatory Evaluating the Polymer-Free Sirolimus Eluting Coronary Stent System VIVO ISAR in Routine Clinical Practice (CELEBRITY Observatory)
Translumina GmbH
3,000 participants
Nov 29, 2023
OBSERVATIONAL
Conditions
Summary
The rationale for this observatory is to evaluate clinical outcomes and collect data of the Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with follow-up at 12 months. All medications and procedures to be used/ performed in this observatory are commonly used/performed for clinical indications as part of standard of care and have well-defined safety profiles.
Eligibility
Inclusion Criteria6
- ≥18 years old
- Ability to provide signed informed consent form.
- Male or non-pregnant female patient (Pregnancy status to be confirmed verbally from the female patient of reproductive age)
- Presentation with acute coronary syndrome or chronic coronary syndrome with stable angina or angina equivalent symptoms or with a positive noninvasive test for ischemia or evidence of a functionally significant coronary stenosis.
- Patient having social security number.
- Patient treated only with Vivo ISAR stent in case of single or multiple vessel stenting
Exclusion Criteria7
- Concurrent participation in another clinical trial.
- Having benefited from an angioplasty of ≤ 1 month with a stent other than Vivo ISAR.
- Planned elective surgery in next 6 months
- Cardiogenic shock/ hemodynamically unstable patients
- Concurrent medical condition with a life expectancy of less than 12 months
- History of cerebrovascular accident in the last 6 months.
- Vulnerable patient under guardianship or curatorship
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The Vivo ISAR is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease.
Locations(19)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06420505